Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Sunday, May 26, 2024 | Back issues
Courthouse News Service Courthouse News Service

Prescription drugs

SAN FRANCISCO — The Ninth Circuit upheld a ruling against a woman who claimed Otsuka America Pharmaceutical’s antipsychotic drug Abilify caused her to develop tardive dyskinesia. The court ruled the woman did not prove the company failed to warn of a known or scientifically knowable risk at the time the drug was distributed.

Read the opinion here.

Categories / Appeals, Briefs, Consumers, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.